POLARIS INSIGHTS

Iovance Biotherapeutics GAAP EPS of -$0. 05 beats by $0. 04, revenue of $121. 47M beats by $5. 9M

This story focuses on Iovance Biotherapeutics GAAP EPS of -$0. 05 beats by $0. 04, revenue of $121. 47M beats….

More from the Markets desk